Basic principles in preclinical cancer chemotherapy.

N Brock, J Pohl, B Schneider
Author Information

Abstract

No abstract text available.

References

  1. Arzneimittelforschung. 1958 Jan;8(1):1-9 [PMID: 13510143]
  2. Cancer Res. 1973 Jun;33(6):1150-8 [PMID: 4718666]
  3. Cancer Treat Rev. 1983 Sep;10 Suppl A:163-4 [PMID: 6414689]
  4. Z Krebsforsch. 1967;69(2):103-201 [PMID: 4230610]
  5. Methods Find Exp Clin Pharmacol. 1987 Sep;9(9):589-94 [PMID: 3437788]
  6. Cancer Treat Rev. 1985 Mar;12(1):1-47 [PMID: 3896483]
  7. Eur J Cancer Clin Oncol. 1987 Jul;23(7):937-48 [PMID: 3665999]
  8. MMW Munch Med Wochenschr. 1975 Aug 22;117(34):1345-8 [PMID: 52114]
  9. Cancer Chemother Rep. 1966 May;50(4):173-218 [PMID: 5938250]
  10. Munch Med Wochenschr. 1958 Dec 5;100(49):1913-8 [PMID: 13622529]
  11. Klin Wochenschr. 1952 Oct 1;30(37-38):882-4 [PMID: 13001136]
  12. Arzneimittelforschung. 1964 Mar;14:171-6 [PMID: 14235978]
  13. Med Welt. 1967 Jul 1;26:1573-8 [PMID: 5616188]
  14. Cancer Treat Rep. 1976 Apr;60(4):445-9 [PMID: 1277220]
  15. Mol Pharmacol. 1971 Sep;7(5):519-29 [PMID: 5139563]
  16. Biochem Pharmacol. 1974 Jan 1;23(1):115-29 [PMID: 4811053]
  17. Science. 1977 Jul 29;197(4302):461-3 [PMID: 560061]
  18. Cancer Treat Rep. 1976 Apr;60(4):327-35 [PMID: 1277208]
  19. Cancer Treat Rep. 1987 Jan;71(1):1-2 [PMID: 3791263]
  20. Med Klin. 1961 Aug 25;56:1421-30 [PMID: 13724502]
  21. Cancer. 1984 Sep 15;54(6 Suppl):1229-38 [PMID: 6467150]
  22. Nature. 1966 May 21;210(5038):866-7 [PMID: 5958471]
  23. Cancer Treat Rep. 1976 Apr;60(4):361-8 [PMID: 1277212]
  24. Arzneimittelforschung. 1980;30(7):1034-40 [PMID: 7191283]
  25. Cancer Treat Rev. 1983 Sep;10 Suppl A:83-92 [PMID: 6414699]
  26. Cancer Treat Rep. 1976 Apr;60(4):437-43 [PMID: 1277219]
  27. Cancer Treat Rev. 1985 Sep;12(3):155-62 [PMID: 3907827]
  28. J Cancer Res Clin Oncol. 1986;111(1):1-12 [PMID: 3949846]
  29. J Natl Cancer Inst. 1989 Jul 5;81(13):988-94 [PMID: 2659805]
  30. Med Welt. 1967 Apr 22;16:985-9 [PMID: 5585096]
  31. Biom Z. 1966;8(3):147-61 [PMID: 5183162]
  32. Cancer Invest. 1988;6(5):513-32 [PMID: 3063337]
  33. N Engl J Med. 1978 Jun 15;298(24):1321-7 [PMID: 77475]
  34. Prog Clin Biol Res. 1988;276:265-86 [PMID: 3051021]
  35. Recent Results Cancer Res. 1986;103:36-40 [PMID: 3461512]
  36. J Natl Cancer Inst. 1990 Jan 17;82(2):96-101 [PMID: 2403594]
  37. Semin Oncol. 1982 Dec;9(4 Suppl 1):2-7 [PMID: 6761865]
  38. Semin Oncol. 1981 Dec;8(4):349-61 [PMID: 7323809]
  39. Adv Pharmacol Chemother. 1984;20:1-20 [PMID: 6398966]
  40. Verh Dtsch Ges Rheumatol. 1972;2:Suppl 2:339-57 [PMID: 5051958]
  41. Dtsch Med Wochenschr. 1975 Aug 29;100(35):1719-26 [PMID: 1098886]
  42. Arzneimittelforschung. 1976;26(10):1783-92 [PMID: 798586]
  43. J Cancer Res Clin Oncol. 1979 Sep;95(1):39-42 [PMID: 91617]

MeSH Term

Animals
Antineoplastic Agents
Cyclophosphamide
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Ifosfamide
Mechlorethamine
Mice
Neoplasms
Nitrogen Mustard Compounds
Rats

Chemicals

Antineoplastic Agents
Nitrogen Mustard Compounds
Mechlorethamine
Cyclophosphamide
trofosfamide
nornitrogen mustard
Ifosfamide

Word Cloud

Created with Highcharts 10.0.0Basicprinciplespreclinicalcancerchemotherapy

Similar Articles

Cited By

No available data.